FDA approves personalized cellular therapy for advanced leukemia developed at Penn and CHOP
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved a personalized cellular therapy developed by…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved a personalized cellular therapy developed by…
On Aug. 24, 2017, Adamas announced that the U.S. Food and Drug Administration (FDA) has approved GOCOVRI (amantadine)…
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
On Jun. 29, 2017, the U.S. Food and Drug Administration unveiled a strategic plan to completely eliminate the…
On Jun. 7, 2017 the U.S. Food and Drug Administration (FDA) approved Endari (L-glutamine oral powder) for patients…
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
On Jan. 19, 2017, Francis S. Collins, M.D., Ph.D. was reappointed Director of the National Institutes of Health…
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
On Jul. 12, 2016, Pfizer announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.S….
On Jun. 12, 2016, the U.S. Food and Drug Administration (FDA) approved Vaxchora, a vaccine for the prevention…
On May 27, 2016, the Food and Drug Administration (FDA) announced it had amended its labeling regulations for…
On Apr. 11, 2016, the U.S. Food and Drug Administration (FDA) announced that it had granted accelerated approval…
On Dec. 14, 2015, the U.S. Food and Drug Administration (FDA) announced it had expanded Merck’s Gardasil 9…
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluad™ (Influenza…
On Nov. 19, 2015, AquaBounty Technologies announced the U.S. Food and Drug Administration (FDA) had approved the Company’s…
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Jun. 8, 2015, the American Medical Association adopted a new policyᅠthat recommended that states have in place…
On Apr. 29, 2015, the U.S. Food and Drug Administration (FDA) announced it had approved Kybella, an injection…
On Mar. 24, 2015, the U.S. Food and Drug Administration (FDA) licensed an additional combined diphtheria and tetanus toxoids…
On Mar. 6, 2015, the The U.S. Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio, Sandoz, Inc.), the…
On Jan. 23, 2015, Novartis announced the US Food and Drug Administration (FDA) had granted accelerated approval of…
On Dec. 23, 2014, the U.S. Food and Drug Administration (FDA) approved a formulation of Novo Nordisk’s diabetes drug, liraglutide,…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…